Goodwin’s Life Sciences team invites you to save the date for its Annual Rare Disease Symposium in Boston on February 5, 2025.
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Having trouble reading this email? View it in your browser.

Goodwin’s Rare Disease Symposium 2025

You're Invited:

Goodwin’s Annual Rare Disease Symposium 2025

Wednesday, February 5, 2025

12:00 PM – 5:30 PM ET

Goodwin

100 Northern Avenue

Boston, MA 02210

Accept - In-Person
Accept - Virtual
Decline

Goodwin’s Life Sciences team invites you to its Annual Rare Disease Symposium in Boston and streamed everywhere on February 5, 2025.  Please join us for an afternoon of engaging fireside chats, inspirational presentations, and networking with your peers in the rare disease community. Our agenda and list of speakers follows below.


 

Agenda


12:00 PM – 1:00 PM EDT | Welcome & Networking Lunch
 
1:00 PM – 4:30 PM EDT | Rare Disease Symposium Program

  • The Patient View
    • David Downing, GRIN1 Dad
    • Jaime McHugh, Rare Disease Mom and NORD Running for Rare Champion
  • The Research View
    • Dr. Shira Rockowitz, PhD, Data Science Director, Boston Children’s Hospital, Children's Rare Disease Collaborative Co-Leader
    • Dr. Piotr Sliz, PhD, Vice President, Chief Research Information Officer & Associate Professor, Boston Children’s Hospital, Children's Rare Disease Collaborative Co-Leader
  • The FDA View
    • Amy Rick, Director of Strategic Coalitions for FDA’s Rare Disease Innovation Hub
  • The Policy View
    • Karin Hoelzer, Senior Director, Patient Advocacy, BIO
    • Jack Kalavritinos, Founder, JK Strategies and the Washington Health Innovation Council, and Former Director, HHS Office of Intergovernmental & External Affairs
    • Judy Stecker, SVP, Burson, and Former HHS Deputy Chief of Staff for Strategy & Operations – Rare Disease Parent & Founder, Wheeler’s Warriors
  • The View from the National Organization for Rare Disorders
    • Pamela Gavin, Chief Executive Officer, NORD
  • The View from the Rare As One Network
    • Heidi Bjornson-Pennell, Senior Program Manager, Science in Society, and Lead, Rare As One Network
  • The Biotech CEO View
    • Paula Ragan, PhD, CEO, X4 Pharmaceuticals 

 4:30 PM – 5:30 PM EDT | Networking Reception


 

X
Instagram
Facebook
LinkedIn
WeChat


We use email tracking. Please see our privacy policy and cookie policy for more information.


Attorney Advertising


This informational piece, which may be considered advertising under the ethical rules of certain jurisdictions, is provided on the understanding that it does not constitute the rendering of legal advice or other professional advice by Goodwin Procter or its lawyers. Prior results do not guarantee a similar outcome. Goodwin Procter is an international legal practice carried on by Goodwin Procter LLP and its affiliated entities. For further information about our offices and the regulatory regimes that apply to them, please refer to our Legal Notices. © 2025 Goodwin Procter.  All rights reserved.  100 Northern Avenue, Boston, Massachusetts 02210 United States. Visit goodwinlaw.com for more information.


goodwinlaw.com